Phase IIa Study of Nimotuzumab to Treat Colorectal Cancer

NCT05278728 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

31

Enrollment

OTHER

Sponsor class

Conditions

Colorectal Cancer

Interventions

DRUG: Nimotuzumab
DRUG: Irinotecan

Sponsor

Biotech Pharmaceutical Co., Ltd.